p53 mutation in hepatocellular carcinoma after aflatoxin exposure.
about
Susceptibility to hepatocellular carcinoma is associated with genetic variation in the enzymatic detoxification of aflatoxin B1Molecular pathogenesis of hepatocellular carcinoma and impact of therapeutic advancesRisk factors for hepatocellular carcinoma in IndiaMutational signatures: the patterns of somatic mutations hidden in cancer genomesThe genetic and epigenetic alterations in human hepatocellular carcinoma: a recent updateComprehensive assessment of cancer missense mutation clustering in protein structuresThe global epidemiology of hepatocellular carcinoma: present and futureDetoxification of Aflatoxin-Contaminated Maize by Neutral Electrolyzed Oxidizing Water.Separate origins of hepatitis B virus surface antigen-negative foci and hepatocellular carcinomas in transgenic HBsAg (alb/psx) mice.249 TP53 mutation has high prevalence and is correlated with larger and poorly differentiated HCC in Brazilian patients.Involvement of DNA damage response pathways in hepatocellular carcinoma.Field cancerization, clonality, and epithelial stem cells: the spread of mutated clones in epithelial sheets.Molecular genetics of hepatocellular neoplasia.Mutation signatures of carcinogen exposure: genome-wide detection and new opportunities for cancer prevention.The clonal origin and clonal evolution of epithelial tumours.Identification of drivers from cancer genome diversity in hepatocellular carcinoma.SIP1 is downregulated in hepatocellular carcinoma by promoter hypermethylationHepatocellular carcinoma and the underlying mechanisms.Expression of mutant p53 protein in hepatocellular carcinoma.Mechanisms of environmental chemicals that enable the cancer hallmark of evasion of growth suppression.Molecular aspects of hepatic carcinogenesis.The significance of immunohistochemistry in the diagnosis and therapy of neoplasms.Hepatocellular carcinoma p53 G > T transversions at codon 249: the fingerprint of aflatoxin exposure?Association among polymorphisms in EGFR gene exons, lifestyle and risk of gastric cancer with gender differences in Chinese Han subjects.Association of TP53 mutations with stem cell-like gene expression and survival of patients with hepatocellular carcinoma.UV and skin cancer: specific p53 gene mutation in normal skin as a biologically relevant exposure measurementCritical roles of p53 in epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma cells.Genetic heterogeneity of hepatocellular carcinomaMolecular dosimetry of aflatoxin exposure: contribution to understanding the multifactorial etiopathogenesis of primary hepatocellular carcinoma with particular reference to hepatitis B virus.Mutation inactivation of Nijmegen breakage syndrome gene (NBS1) in hepatocellular carcinoma and intrahepatic cholangiocarcinoma.TP53 mutations in workers exposed to occupational carcinogens.Aflatoxins and fumonisins contamination of home-made food (weanimix) from cereal-legume blends for childrenHepatocellular carcinoma: are we making progress?Classification of hepatocellular carcinoma according to hepatocellular and biliary differentiation markers. Clinical and biological implications.Seropositivity of hepatitis B e antigen and hepatocellular carcinoma.Duck hepatitis B virus infection, aflatoxin B1 and liver cancer in domestic Chinese ducks.Codon 249 mutation of the p53 gene is a rare event in hepatocellular carcinomas from ethnic Chinese in Singapore.Aflatoxin sufferer and p53 gene mutation in hepatocellular carcinomap53 expression in hepatocellular carcinoma in a population in Singapore with endemic hepatitis B virus infection.Selective induction of apoptosis in Hep 3B cells by topoisomerase I inhibitors: evidence for a protease-dependent pathway that does not activate cysteine protease P32.
P2860
Q24563504-8402EC6E-DA47-4908-A465-94067E111163Q26745338-9709456F-1974-4D90-84FE-BE2114C6DAEAQ26830794-A82AA14B-B314-4907-A0E3-A71510929A2EQ26850125-392FFD6C-F644-463C-9477-BD36DC84AA53Q27003050-6EC52695-AD81-487D-A08B-A3C0C12FC106Q28606437-17C45649-9D60-45B6-90B7-74AB77DBE864Q28654353-632F4E7D-2299-4793-9B99-0C366731BE37Q30488488-0631202D-75A5-4A7F-B8DF-012099D56E65Q33248641-17C3748D-3F97-4976-8C3F-3CF9431D5002Q33475143-171DD226-8C3F-4FEB-AC39-93660919CBFEQ33616812-AE65FB58-D7FB-4B5F-8860-EC8CC390FF84Q33643333-9537FBC0-4AE2-44AB-BA6C-21671A40CF3FQ33680701-8B7B9BE5-EC22-4D87-840D-5A5E3F939EF8Q33772624-3EFEBC23-7F8F-488C-BCB5-2284299FC3C8Q33890376-15DCE693-4D10-48A5-A1CB-2C3291CD80E5Q33907993-84EA8421-ED5C-4AC6-AA9E-1880D96D6F34Q33924619-8A2AFC2B-4E79-4354-8807-DD585B24D8CCQ33956158-7F7FCD3E-F159-4604-B3E6-D2B7A32EED94Q34378463-2F3C96D4-BEAA-4608-A967-B88889F3E116Q34482050-1BFB584E-2B42-4CF6-805D-00E2F2150884Q34564963-917CD183-7CC7-4B77-8816-40899732B313Q34602545-8F0373EB-410C-4C9D-B74A-2A684F76BD8BQ34638490-37915604-B4D7-4471-BDC8-79E6D2B48FC9Q34650974-4CA32D77-B856-4C61-8345-92E44B9A1BD7Q34672668-53828535-8320-4F8C-869A-74E70B73D723Q34961006-0A2CA08E-9ACE-4DA3-9DA8-10841BA6F641Q34984096-133C6DA2-6DBE-4958-A7FF-69DCB0D10B75Q35004899-4D8F5891-58A9-41D3-AEC8-A048AE5F3965Q35031497-10946D5B-2D00-431D-93EA-8063DE6D63D6Q35070267-7EB0E0F0-F283-4634-A3B4-5BDC65643A8EQ35078737-586DC623-CAC7-44E1-B891-65856E5697EFQ35104623-8CAD5AF4-75F2-4209-8F09-72E3C8E798F1Q35193283-071F5ABF-7C9B-4F4A-9A13-69248CFE7BBFQ35782193-CC9D1725-1219-4ADE-814C-0C83318E38ADQ35794991-EA15450D-5C41-4EE6-A6B8-C1EC0BA13DD6Q35978000-945D5F77-2A2F-44AA-8158-998239E2C14AQ36081903-7ECB83AD-92F1-4AC2-A800-FF61B0B7CA08Q36620217-38BC3814-4ECE-4534-A6DF-ADFB1FF0EBDBQ37258346-8AA997A0-FC8F-4A87-B4B1-D775E010919AQ37361913-1A1484A7-76C5-454B-BFF8-143EE3C432EB
P2860
p53 mutation in hepatocellular carcinoma after aflatoxin exposure.
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年学术文章
@wuu
1991年学术文章
@zh
1991年学术文章
@zh-cn
1991年学术文章
@zh-hans
1991年学术文章
@zh-my
1991年学术文章
@zh-sg
1991年學術文章
@yue
1991年學術文章
@zh-hant
name
p53 mutation in hepatocellular carcinoma after aflatoxin exposure.
@en
p53 mutation in hepatocellular carcinoma after aflatoxin exposure.
@nl
type
label
p53 mutation in hepatocellular carcinoma after aflatoxin exposure.
@en
p53 mutation in hepatocellular carcinoma after aflatoxin exposure.
@nl
prefLabel
p53 mutation in hepatocellular carcinoma after aflatoxin exposure.
@en
p53 mutation in hepatocellular carcinoma after aflatoxin exposure.
@nl
P1433
P1476
p53 mutation in hepatocellular carcinoma after aflatoxin exposure.
@en
P2093
P304
P356
10.1016/0140-6736(91)92236-U
P407
P577
1991-11-01T00:00:00Z